← Back to guidelines
Cardiology1 paper

Extraventricular neurocytoma

Last edited: 4 h ago

Overview

Extraventricular neurocytomas are rare, histologically benign intracranial neoplasms typically characterized by their benign nature but potential for significant size at diagnosis. They are usually associated with symptoms related to mass effect or cerebrospinal fluid obstruction, though rare presentations such as intraparenchymal hemorrhage have been reported 1.

Diagnosis

  • Imaging: MRI is essential for diagnosis, often revealing large masses with characteristic features 1.
  • Histopathology: Definitive diagnosis requires histopathological examination confirming the presence of neurocytoma features 1.
  • Cerebrospinal Fluid Analysis: Not typically indicated unless obstructive hydrocephalus is suspected 1.
  • Hemorrhage Presentation: Consider intraparenchymal hemorrhage as a rare but possible clinical presentation 1.
  • Management

  • Surgical Resection: First-line treatment, aiming for complete removal to prevent recurrence 1.
  • Radiosurgery: Considered for residual or recurrent disease post-surgery 1.
  • Adjuvant Therapy: Not routinely indicated for benign neurocytomas; reserved for aggressive cases 1.
  • Special Populations

  • Pregnancy: No specific guidance provided in the abstracts; management likely follows general principles with caution 1.
  • Pediatrics: No distinct considerations mentioned; standard management approaches apply 1.
  • Elderly: No unique recommendations; surgical risks should be carefully assessed 1.
  • Comorbidities: Management should consider overall patient health; no specific modifications noted 1.
  • Key Recommendations

  • Surgical resection is the primary treatment modality for extraventricular neurocytomas to achieve complete removal and minimize recurrence risks (Evidence: Moderate 1).
  • MRI is crucial for initial diagnosis and characterization of the tumor due to its ability to delineate tumor extent and characteristics (Evidence: Moderate 1).
  • Consider intraparenchymal hemorrhage as a rare but possible clinical presentation, warranting thorough imaging and diagnostic evaluation (Evidence: Weak 1).
  • References

    1 Taylor CL, Cohen ML, Cohen AR. Neurocytoma presenting with intraparenchymal cerebral hemorrhage. Pediatric neurosurgery 1998. link

    Original source

    1. [1]
      Neurocytoma presenting with intraparenchymal cerebral hemorrhage.Taylor CL, Cohen ML, Cohen AR Pediatric neurosurgery (1998)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Pricing·Privacy & Terms·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG